Astrocytoma Latest Advances

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Journal: Expert review of anticancer therapy

Published: June 24, 2026

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Journal: Expert review of neurotherapeutics

Published: June 24, 2026

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 23, 2026

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Journal: BJC reports

Published: June 23, 2026

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Journal: Molecular biology reports

Published: June 23, 2026

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Journal: Journal of neurosurgical sciences

Published: June 23, 2026

Glioblastoma-derived extracellular vesicles released after radiation promote cognitive impairment through NFκB-mediated microglial activation.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Intra-slide calibration technology improves immunohistochemical harmonization within and between anatomic pathology laboratories.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

In silico investigation of Panchagavya Ghrita's anticancer potential against glioblastoma: a network pharmacology and molecular docking study.

Journal: Journal of receptor and signal transduction research

Published: June 20, 2026

Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.

Journal: Epigenomics

Published: June 19, 2026

TFPI2 promotes NK cell-mediated glioblastoma killing through adhesion and checkpoint control.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 18, 2026

Canine high-grade astrocytomas are currently distinct from human glioblastomas.

Journal: Veterinary pathology

Published: June 18, 2026

Astrocytoma Latest Advances

Find the Latest Research About Astrocytoma

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Glioblastoma-derived extracellular vesicles released after radiation promote cognitive impairment through NFκB-mediated microglial activation.

Glioblastoma-derived extracellular vesicles released after radiation promote cognitive impairment through NFκB-mediated microglial activation.

Intra-slide calibration technology improves immunohistochemical harmonization within and between anatomic pathology laboratories.

Intra-slide calibration technology improves immunohistochemical harmonization within and between anatomic pathology laboratories.

In silico investigation of Panchagavya Ghrita's anticancer potential against glioblastoma: a network pharmacology and molecular docking study.

In silico investigation of Panchagavya Ghrita's anticancer potential against glioblastoma: a network pharmacology and molecular docking study.

Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.

Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.

TFPI2 promotes NK cell-mediated glioblastoma killing through adhesion and checkpoint control.

TFPI2 promotes NK cell-mediated glioblastoma killing through adhesion and checkpoint control.

Canine high-grade astrocytomas are currently distinct from human glioblastomas.

Canine high-grade astrocytomas are currently distinct from human glioblastomas.